U.S. Genomics announced today that John J. Canepa has been promoted to President, Chief Executive Officer and member of the Board of Directors. U.S. Genomics is the leading developer of single molecule analysis technologies for life science and biodefense applications, with a platform that directly detects and quantitates individual molecules of miRNA, DNA, RNA, and proteins without the need for amplification.
